{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:24:48Z","timestamp":1769923488180,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.clim.2009.03.523","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T04:54:15Z","timestamp":1240462455000},"page":"246-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I"],"prefix":"10.1016","volume":"132","author":[{"given":"Sabrina","family":"Shandley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Krolick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2009.03.523_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0065-2776(08)60847-0","article-title":"Myasthenia gravis","volume":"42","author":"Lindstrom","year":"1988","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.clim.2009.03.523_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clim.2009.03.523_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2009.03.523_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mus.880060213","article-title":"Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates","volume":"6","author":"Hohlfeld","year":"1983","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clim.2009.03.523_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2009.03.523_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.1981.tb33741.x","article-title":"Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer","volume":"377","author":"Tindall","year":"1981","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.clim.2009.03.523_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-1229(92)90073-W","article-title":"Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: subsetting by preparative isoelectric focusing","volume":"62","author":"Thompson","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2009.03.523_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(89)90107-0","article-title":"Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen","volume":"24","author":"Yeh","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2009.03.523_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.146.2.663","article-title":"Clonotypic analysis of anti-acetylcholine receptor antibodies from EAMG-sensitive Lewis rats and EAMG-resistant Wistar Furth rats","volume":"146","author":"Zoda","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/cimm.1996.0209","article-title":"Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis","volume":"172","author":"Krolick","year":"1996","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/clim.1999.4828","article-title":"Chemokine production by rat myocytes exposed to interferon-gamma","volume":"94","author":"Reyes-Reyna","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/clim.1999.4821","article-title":"A monoclonal Lewis rat myocyte line that responds to interferon-gamma: responsiveness with the potential to influence subsequent interactions with the immune system","volume":"94","author":"Stegall","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/clim.1999.4822","article-title":"Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis","volume":"94","author":"Stegall","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0165-5728(01)00401-5","article-title":"Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by up-regulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis","volume":"119","author":"Stegall","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2009.03.523_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-5728(01)00414-3","article-title":"Acetylcholine receptor-reactive antibody induces nitric oxide production by a rat skeletal muscle cell line: influence of cytokine environment","volume":"120","author":"Garcia","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2009.03.523_bib17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.169.3.1579","article-title":"Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating MCP-1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis","volume":"169","author":"Reyes-Reyna","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(02)00023-2","article-title":"Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis","volume":"106","author":"Garcia","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2004.05.002","article-title":"Short-circuiting autoimmune disease by target-tissue-derived nitric oxide","volume":"113","author":"Garcia","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clim.2006.07.005","article-title":"Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis","volume":"121","author":"Krolick","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Tzartos","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2009.03.523_bib22","unstructured":"Purification of antibodies by hydroxyapatite chromatography. In: Antibodies: a Laboratory Manual (E. Harlow and D. Lane, eds.), Cold Spring Harbor Laboratory, 1988, pp. 306\u2013307."},{"key":"10.1016\/j.clim.2009.03.523_bib23","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4049\/jimmunol.144.5.1654","article-title":"T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function","volume":"144","author":"Yeh","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-5728(87)90013-0","article-title":"Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor","volume":"14","author":"Olsberg","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2009.03.523_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0167-4889(99)00117-2","article-title":"Identification of soluble interleukin-4 in rat glomerular epithelial cells","volume":"1452","author":"Chen","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2009.03.523_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","article-title":"The IL-4 receptor: signaling mechanisms and biologic functions","volume":"17","author":"Nelms","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4049\/jimmunol.140.2.456","article-title":"Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells","volume":"140","author":"Lowenthal","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jlb.57.5.763","article-title":"IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2","volume":"57","author":"Giri","year":"1995","journal-title":"J. Leuk. Biol."},{"key":"10.1016\/j.clim.2009.03.523_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.156.2.663","article-title":"IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection","volume":"156","author":"Nishimura","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.03.523_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cytogfr.2006.05.001","article-title":"IL-15\/IL-15 receptor biology: a guided tour through an expanding universe","volume":"17","author":"Budagian","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2009.03.523_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.181.2.547","article-title":"Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction","volume":"181","author":"Gu","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.03.523_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-\u03b3) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.03.523_bib34","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y","article-title":"IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease","volume":"28","author":"Moiola","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib35","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-\u03b3 receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2249.1997.3881284.x","article-title":"Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats","volume":"108","author":"Shi","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/clim.2000.4850","article-title":"Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis","volume":"95","author":"Wang","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molimm.2004.04.027","article-title":"STAT-1 is activated by IL-4 and IL-13 in multiple cell types","volume":"41","author":"Wang","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2009.03.523_bib39","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1210\/endo.136.8.7628408","article-title":"Interleukin-15: a novel anabolic cytokine for skeletal muscle","volume":"136","author":"Quinn","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.clim.2009.03.523_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/bbrc.1997.7414","article-title":"Interleukin-15 stimulates C2 skeletal myoblast differentiation","volume":"239","author":"Quinn","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2009.03.523_bib41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Carb\u00f3","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clim.2009.03.523_bib42","doi-asserted-by":"crossref","first-page":"C1298","DOI":"10.1152\/ajpcell.00496.2006","article-title":"Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy","volume":"292","author":"Pistilli","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661609005920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661609005920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:55:59Z","timestamp":1761494159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661609005920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1521661609005920"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2009.03.523","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2009.03.523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}